Keela Weeks
Primary Care · Roswell, GANPI 1831315431
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 38.4% of the total.
Across 137 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$508
- Novo Nordisk$290
- Astellas Pharma US Inc$244
- Pfizer$115
- Biohaven Pharmaceutical Holding Company Ltd.$85
- plus $456 from 13 others
What the payments were for
- Food & beverage$2,66697%
- Education$903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $1,057 |
| Lilly USA, LLC | 26 | $508 |
| Novo Nordisk | 17 | $290 |
| Astellas Pharma US Inc | 8 | $244 |
| Pfizer | 6 | $115 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $85 |
| AstraZeneca | 3 | $67 |
| GSK | 4 | $64 |
| Exact Sciences | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| Lundbeck LLC | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Abbott | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
How this compares
$2,756 in reported general payments places this provider in the 80th percentile of 235 primary care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 58 | $62,549 |
| OzempicSemaglutide | 49 | $52,279 |
| JanuviaSitagliptin Phosphate | 23 | $17,944 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $6,762 |
| MyrbetriqMirabegron | 12 | $5,309 |
| SynthroidLevothyroxine Sodium | 27 | $2,278 |
| Levothyroxine Sodium | 133 | $1,346 |
| Bupropion XlBupropion Hcl | 82 | $1,343 |
| Nitroglycerin PatchNitroglycerin | 11 | $1,077 |
| Atorvastatin Calcium | 130 | $939 |
| Pantoprazole Sodium | 65 | $916 |
| Escitalopram Oxalate | 70 | $895 |
| Nifedipine ErNifedipine | 26 | $774 |
| Memantine Hcl | 23 | $770 |
| Valsartan | 32 | $736 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $508 | $62,54958 claims |
| Novo NordiskOzempic | $290 | $52,27949 claims |
| Astellas Pharma US IncMyrbetriq | $244 | $5,30912 claims |
| AbbVieSynthroid | $1,057 | $2,27827 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 235 primary care providers in Georgia.
Other primary care in Roswell
- Melissa SelbyRoswell$4K
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
- Zanetta BryantNewnan$11K
- Hannah CummingsSuwanee$9K
- Michelle LadewigGainesville$7K
- Lucia OcanoviciuCanton$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.